0G8X

Noticias Immunovia Ab (publ)

Las mejores ofertas para acceder a los datos en tiempo real!
Real-time Level 1 for London Stock Exchange
Suscripción Mensual
Por sólo
US$29.56
Real-time Level 2 for London Stock Exchange
Suscripción Mensual
Por sólo
US$77.61
Real-time London Stock Exchange & FTSE
Suscripción Mensual
Por sólo
US$88.69
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Immunovia Ab (publ) 0G8X London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.0% 191.40 18:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
191.40 191.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/11/202102:11PRNUSImmunovia appoints new Senior Director Investor Relations..
26/11/202102:10PRNUSImmunovia appoints new Senior Director Investor Relations..
23/11/202102:22PRNUSImmunovia Honored World Pancreatic Cancer Day by a Grand..
23/11/202102:08PRNUSImmunovia Honored World Pancreatic Cancer Day by a Grand..
11/11/202109:15PRNUSImmunovia Publishes Report for the Third Quarter 2021
11/11/202109:12PRNUSImmunovia Publishes Report for the Third Quarter 2021
05/11/202108:08PRNUSImmunovia to Present at Jefferies London Healthcare..
05/11/202108:06PRNUSImmunovia to Present at Jefferies London Healthcare..
29/10/202108:49PRNUSImmunovia, Inc.'s Medical Director Dr. Thomas King Invited..
29/10/202108:41PRNUSImmunovia, Inc.'s Medical Director Dr. Thomas King Invited..
29/10/202102:35PRNUSInvitation to Presentation of Immunovia's Interim Report..
29/10/202102:33PRNUSInvitation to Presentation of Immunovia's Interim Report..
28/10/202101:58PRNUSImmunovia receives Presidential Poster Award at the American..
28/10/202101:56PRNUSImmunovia receives Presidential Poster Award at the American..
25/10/202103:12PRNUSNomination Committee appointed for the 2022 Annual General..
25/10/202103:09PRNUSNomination Committee appointed for the 2022 Annual General..
15/10/202106:48PRNUSImmunovia Appoints New Chief Financial Officer
15/9/202104:18PRNUSThe US based Pancreatic Cancer Action Network informs their..
14/9/202111:27PRNUSThe US based Pancreatic Cancer Action Network informs their..
14/9/202111:14PRNUSThe US based Pancreatic Cancer Action Network informs their..
13/9/202104:43PRNUSImmunovia enters licensing agreement with JW BioScience for..
13/9/202104:38PRNUSImmunovia enters licensing agreement with JW BioScience for..
03/9/202107:48PRNUSBoard member of Immunovia purchases shares in the company
03/9/202107:47PRNUSBoard member of Immunovia purchases shares in the company
19/8/202109:32PRNUSImmunovia Publishes Report for the Second Quarter 2021
19/8/202109:30PRNUSImmunovia Publishes Report for the Second Quarter 2021
11/8/202109:19PRNUSInvitation to Presentation of Immunovia's Interim Report..
11/8/202109:18PRNUSInvitation to Presentation of Immunovia's Interim Report..
10/8/202106:25PRNUSImmunovia Provides Updates on the Price for the IMMrayTM..
10/8/202106:24PRNUSImmunovia Provides Updates on the Price for the IMMrayTM..
04/8/202106:40PRNUSImmunovia, Inc. Receives Approval to Begin Testing Patients..
04/8/202106:37PRNUSImmunovia, Inc. Receives Approval to Begin Testing Patients..
30/6/202110:01PRNUSImmunovia, Inc. Receives Certificate of Registration -..
30/6/202109:57PRNUSImmunovia, Inc. Receives Certificate of Registration -..
28/5/202105:40PRNUSCEO Patrik Dahlen purchases Immunovia shares
28/5/202105:38PRNUSCEO Patrik Dahlen purchases Immunovia shares
27/5/202109:38PRNUSImmunovia to Host a Key Opinion Leader Event on the Clinical..
27/5/202109:34PRNUSImmunovia to Host a Key Opinion Leader Event on the Clinical..
12/5/202102:31PRNUSMember of Immunovia's Board of Directors purchases shares in..
12/5/202102:28PRNUSMember of Immunovia's Board of Directors purchases shares in..
07/5/202103:29PRNUSAnnual General Meeting - Immunovia AB
07/5/202103:27PRNUSAnnual General Meeting - Immunovia AB
04/5/202110:04PRNUSMembers of Immunovia's Board of Directors purchase shares in..
04/5/202110:02PRNUSMembers of Immunovia's Board of Directors purchase shares in..
28/4/202109:15PRNUSImmunovia Reports Interim Report January - March 2021
28/4/202109:13PRNUSImmunovia Reports Interim Report January - March 2021
22/4/202102:54PRNUSImmunovia reiterates its road to reimbursement for the..
22/4/202102:52PRNUSImmunovia reiterates its road to reimbursement for the..
21/4/202116:53PRNUSImmunovia presents update on US market size for IMMray™..
21/4/202116:51PRNUSImmunovia presents update on US market size for IMMray™..
Ver más noticias sobre esta acción »
Su Consulta Reciente
LSE
0G8X
Immunovia ..
Regístrese ahora para ver estas acciones en su Monitor streaming ADVFN.

Usted puede agregar y ver hasta 110 símbolos de sus acciones favoritas al mismo tiempo y completamente gratis.

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V: D:20211128 00:57:01